Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
Clinical trial NCT02901548 · TERMINATED
Trial details
- NCT number
- NCT02901548
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-16
- Primary completion
- 2020-07-24
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.